http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101710553-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P17-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y401-02013 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-63 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
| filingDate | 2014-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101710553-B1 |
| titleOfInvention | 2-deoxyribose 5-phosphate aldolase mutant from Haemophilus influenzae Rd KW20 |
| abstract | More particularly, the present invention relates to a 2-deoxyribose 5-phosphate aldolase mutant derived from the strain Haemophilus influenzae Rd KW20 and a 2-deoxyribose 5-phosphate aldolase mutant derived from the above- Or a recombinant microorganism into which the gene is introduced and a recombinant microorganism are cultured in a culture medium containing the same, or a method for producing the 2-deoxyribose 5-phosphate aldolase mutant. The 2-deoxyribose 5-phosphate aldolase mutant according to the present invention is low in substrate inhibition against acetaldehyde and excellent in activity, so it is useful for the production of lactol including an antiviral nucleoside, an anticancer agent and a statin-based hyperlipemia therapeutic agent Do. |
| priorityDate | 2014-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 906.